Alleviating Overbought Conditions
Market Trends

NVIDIA Stock Is Constructively Alleviating Overbought Conditions

NVDA Stock: Constructive Developments BUZ INVESTORS  Alleviating Overbought Conditions NVIDIA Corporation (NASDAQ:NVDA) stock went on an epic run last year, where the share price appreciated by 226.92%. This epic run was supported by a number of technical indicators. However, these indicators are now suggesting that the path of least resistance is geared towards lower prices. […]

XBiotech's stock plummets
Market Trends

XBiotech’s stock plummets premarket after poor review for cancer treatment

XBiotech Announces Outcome of EMA’s Oral Explanation Meeting BUZ INVESTORS PRESS RELEASE XBiotech’s stock plummets   XBiotech Inc. (NASDAQ:XBIT) announced today that the European Medicines Agency (EMA) rendered a negative “trend” vote after meeting with the Company to discuss the “Day 180 List of Outstanding Issues” related to the Company’s marketing authorization application (MAA) for its […]

INVESTORSBUZ PRESS RELEASE Valeant says plaque psoriasis drug Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee
Market Trends

Valeant says plaque psoriasis drug will cost $3,500 a month

Valeant’s Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis INVESTORSBUZ PRESS RELEASE Valeant says plaque psoriasis drug Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), the […]